Listed

ICU Medical Inc: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Mar 16, 2018 and accepted by EDGAR at Mar 16, 2018, 17:20 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2017-01-01 to 2017-12-31$1.29bnus-gaap:Revenues
Gross profit3 months2017-10-01 to 2017-12-31$137.5mus-gaap:GrossProfit
Gross profit12 months2017-01-01 to 2017-12-31$426.1mus-gaap:GrossProfit
Research and development12 months2017-01-01 to 2017-12-31$51.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2017-01-01 to 2017-12-31$304.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2017-01-01 to 2017-12-31−$15.1mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$2.0mus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31−$17.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-10-01 to 2017-12-31$49.7mus-gaap:NetIncomeLoss
Net income12 months2017-01-01 to 2017-12-31$68.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-10-01 to 2017-12-31$2.33us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2017-01-01 to 2017-12-31$3.29us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-10-01 to 2017-12-31$2.47us-gaap:EarningsPerShareBasic
Basic EPS12 months2017-01-01 to 2017-12-31$3.50us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2017-01-01 to 2017-12-3120,858,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2017-01-01 to 2017-12-31$154.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2017-01-01 to 2017-12-31$74.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2017-01-01 to 2017-12-31$4.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-12-31$290.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$864.7mus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$1.50bnus-gaap:Assets
Current liabilitiesAt period end2017-12-31$210.3mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2017-12-31$1.20bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000883984-18-000010. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.